Each year, around 100,000 people worldwide receive solid organ transplants, and from the day of their surgery to the day they die almost all of them have to take daily immunosuppressant drugs to prevent the body from attacking the new organ. But an experimental procedure in which patients receive some of the donor's bone marrow in addition to the organ hopes to eliminate the need for lifelong drug therapy. Elie Dolgin talks to the scientists who are rejecting the idea of transplantation as usual.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Kawau, T. et al. N. Engl. J. Med. 358, 353–361 (2008).
Engels, E.A. et al. J. Am. Med. Assoc. 306, 1891–1901 (2011).
Owen, R.D. Science 102, 400–401 (1945).
Billingham, R.E., Brent, L. & Medawar, R.B. Nature 172, 603–606 (1953).
Main, J.M. & Prehn, R.T. J. Natl. Cancer Inst. 15, 1023–1029 (1955).
Ildstad, S.T. & Sachs, D.H. Nature 307, 168–170 (1984).
Huang, C.A. et al. J. Clin. Invest. 105, 173–181 (2000).
Kawai, T. et al. Transplantation 59, 256–262 (1995).
Spitzer, T.R. et al. Transplantation 91, 672–676 (2011).
Millan, M.T. et al. Transplantation 73, 1386–91 (2002).
Scandling, J.D., Busque, S., Shizuru, J.A., Engleman, E.G. & Strober, S. N. Engl. J. Med. 365, 1359–1360 (2011).
Huang, Y. et al. Blood 117, 2494–2505 (2011).
About this article
Cite this article
Dolgin, E. An act of tolerance. Nat Med 18, 12–16 (2012). https://doi.org/10.1038/nm0112-12
This article is cited by
Nature Medicine (2016)
Nature Medicine (2012)